Altor BioScience Corporation
Altor BioScience Licenses T-cell Receptors Targeting HIV and Hepatitis C from Massachusetts General Hospital
Published in Physician Law Weekly, September 24th, 2008
Altor BioScience Corporation (Altor) announced that it has entered into an agreement with Massachusetts General Hospital (MGH) for exclusive, worldwide rights to develop and commercialize T-cell receptors (TCRs) specific for cells infected by HIV and Hepatitis C Virus (HCV). The license has resulted from the success of Altor's collaboration established in 2004 with Howard Hughes Medical Institute and the Partners AIDS Research Center at MGH. Altor has already successfully improved and converted the licensed TCRs into targeted therapeutic reagents using its Soluble T-cell Antigen Receptor (STAR(TM)) technology.
Hing Wong, Ph.D., President & CEO of Altor, commented, "The...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
Source: Physician Law Weekly (2008-09-24)
More Articles from Physician Law Weekly
- ACLJ
ACLJ Secures Federal Court Jury Verdict for Teen Challenge in TN -- Nearly $1 Million Damage Award & Finding of Religious Discrimination - Advent International
Advent International Announces Partnership With Former Old Navy President Jenny J. Ming - American Civil Liberties Union
ACLU Challenges State Department's Refusal to Issue Passports to U.S. Citizens - Amerinet Inc.
Amerinet Partners with Campaign to End Obesity to Raise Awareness - Analog Devices, Inc.
Analog Devices Maximizes Image Quality and Power Performance Across Multiple Ultrasound Platforms - APP Pharmaceuticals, Inc.
APP Pharmaceuticals Announces Trading Information on NASDAQ of Contingent Value Rights Associated with the Acquisition by Fresenius - More from this issue of Physician Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
